| ST. LOUIS, MO – McGrath & Associates has teamed with design firm CE & IC to complete an expansion of one of Sigma-Aldrich Corporation’s (NASDAQ: SIAL) facilities in St. Louis designed to support its custom manufacturing services business unit, SAFC® Commercial (www.sigma-aldrich.com/safc).
In St. Louis, SAFC is investing in commercial-scale manufacturing capacity for Antibody Drug Conjugates (ADCs). ADC technologies have shown exceptional promise in targeted therapies for chronic diseases such as cancer. The expansion at the St. Louis site is expected to be complete by mid-2015 and will complement the Company’s existing clinical ADC manufacturing suite. The updated facility will feature segregated areas for high-potent solids handling and manufacturing and aseptic bulk filling of product. The project design includes additional commercial-scale manufacturing capacity to seamlessly accommodate future increases in demand for ADC production. The St. Louis expansion will enable continuous scale-up of ADCs, from preclinical to clinical phases and into commercial-scale production. McGrath & Associates is a 100 percent employee-owned general contractor and construction management firm specializing in commercial, health care, industrial, institutional and pharmaceutical construction projects since 1983. McGrath is a member of the Associated General Contractors, the St. Louis Construction OSHA Partnership and has been named “General Contractor of the Year” by the American Subcontractors Association Midwest Council five times out of 16 nominations. For more information, call Ken Knobbe at (314) 772-7600 or visit www.mcgrathconstruction.com. # # #
Media Contact |
Source: McGrath – News